Skip to main content

Pacer BioThreat Strategy ETF News

Biotech Looks Past Its Latest <I>Annus Horribilis</I>

A long line of applications, a new FDA commissioner and lower values may kick-start the sector.

Gilead to Acquire Triangle Pharmaceuticals

The $464 million cash deal will combine two companies that specialize in HIV treatments.

Biotechs Tune Up for the Mating Dance

Flush with cash and eager for new products, some companies may get the urge to merge.


Breaking News

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.